Sabby Management’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-836,615
| Closed | -$360K | – | 43 |
|
|
2025
Q1 | $360K | Buy |
+836,615
| New | +$360K | 1.06% | 12 |
|
|
2022
Q1 | – | Sell |
-20
| Closed | -$23K | – | 106 |
|
|
2021
Q4 | $23K | Buy |
+20
| New | +$23K | ﹤0.01% | 102 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 108 |
|
|
2021
Q2 | – | Sell |
-306
| Closed | -$564K | – | 97 |
|
|
2021
Q1 | $564K | Buy |
+306
| New | +$564K | 0.11% | 51 |
|
|
2020
Q4 | – | Sell |
-57
| Closed | -$178K | – | 77 |
|
|
2020
Q3 | $178K | Buy |
+57
| New | +$178K | 0.03% | 55 |
|
|
2020
Q2 | – | Sell |
-73
| Closed | -$128K | – | 64 |
|
|
2020
Q1 | $128K | Buy |
+73
| New | +$128K | 0.05% | 33 |
|
|
2019
Q4 | – | Sell |
-115
| Closed | -$278K | – | 59 |
|
|
2019
Q3 | $278K | Buy |
+115
| New | +$278K | 0.15% | 41 |
|